Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward D Ball

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Experimental Hematology|May 24, 2003
The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expressionLarisa Balaian, Rui-kun Zhong, Edward D Ball
Anti-Cancer Drugs|October 30, 2004
Targeting gastrin-releasing peptide receptors for cancer treatmentJiehua Zhou, Jian Chen, Michael Mokotoff, et al.
Expert Opinion on Biological Therapy|September 29, 2020
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adultsBenjamin H Goldenson, Aaron M Goodman, Edward D Ball
Experimental Hematology|February 6, 2008
Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cellsRui-Kun Zhong, Thomas A Lane, Edward D Ball
Clinical Medicine Insights. Oncology|January 15, 2021
Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?Ah-Reum Jeong, Edward D Ball, Aaron Michael Goodman
Oncology (Williston Park, N.Y.)|February 17, 2017
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed MyelofibrosisAaron M Goodman, Megan Rust, Caitlin Costello, et al.
Statistics in Medicine|March 10, 2010
Toxicity-evaluation designs for phase I/II cancer immunotherapy trialsKaren Messer, Loki Natarajan, Edward D Ball, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2014
A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfallRebecca L Johnson, Saskia Boisot, Edward D Ball, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2009
Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSDMeghana Trivedi, Sam Martinez, Sue Corringham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2017
Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host DiseaseAmritha Balakrishnan, Nicholas Gloude, Roman Sasik, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Experimental Hematology|May 24, 2003
The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expressionLarisa Balaian, Rui-kun Zhong, Edward D Ball
Anti-Cancer Drugs|October 30, 2004
Targeting gastrin-releasing peptide receptors for cancer treatmentJiehua Zhou, Jian Chen, Michael Mokotoff, et al.
Expert Opinion on Biological Therapy|September 29, 2020
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adultsBenjamin H Goldenson, Aaron M Goodman, Edward D Ball
Experimental Hematology|February 6, 2008
Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cellsRui-Kun Zhong, Thomas A Lane, Edward D Ball
Clinical Medicine Insights. Oncology|January 15, 2021
Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?Ah-Reum Jeong, Edward D Ball, Aaron Michael Goodman
Oncology (Williston Park, N.Y.)|February 17, 2017
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed MyelofibrosisAaron M Goodman, Megan Rust, Caitlin Costello, et al.
Statistics in Medicine|March 10, 2010
Toxicity-evaluation designs for phase I/II cancer immunotherapy trialsKaren Messer, Loki Natarajan, Edward D Ball, et al.
International Journal of Clinical and Experimental Pathology|January 16, 2014
A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfallRebecca L Johnson, Saskia Boisot, Edward D Ball, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2009
Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSDMeghana Trivedi, Sam Martinez, Sue Corringham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2017
Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host DiseaseAmritha Balakrishnan, Nicholas Gloude, Roman Sasik, et al.
Pageof 7